Processa Pharmaceuticals Operating Cycle Over Time
| PCSA Stock | USD 2.88 -0.04 -1.37% |
Fundamental trend analysis helps separate temporary noise from persistent changes in Processa Pharmaceuticals.
Pair Processa Pharmaceuticals Performance with Processa Pharmaceuticals Correlation for supplemental context on Processa Pharmaceuticals. This supports a more complete research view.Investors evaluate Processa Pharmaceuticals using market value and book value, each describing different facets of the business. Processa Pharmaceuticals' market capitalization is 6.53 M. A P/B ratio of 1.12 indicates the market values Processa Pharmaceuticals above its accounting book value. Enterprise value stands at 216.99 K. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Processa Pharmaceuticals are related but not identical, and they can diverge across cycles. For Processa Pharmaceuticals, key inputs include a P/B ratio of 1.12, and ROE of -2.71%. Market price reflects the current exchange level formed by active bids and offers.
Peer Comparison: Operating Cycle
Compare Processa Pharmaceuticals and related stocks such as Briacell Therapeutics, Curis Inc, and Entero Therapeutics Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCTX | 0.0 | 0.0865 | 0.0865 | 0.0865 | 0.0865 | 0.0865 | 1.0631 | 0.0 | 158 | 3.9 K | 9.7 K | 9.7 K | 9.7 K | 9.7 K | 9.7 K | 8.7 K | 9.2 K |
| CRIS | 6.8521 | 1.0401 | -788 | -878 | -454 | -986 | -1 K | 113 | -436 | 118 | 103 | 111 | 107 | 102 | 112 | 129 | 135 |
| PALI | 2.9839 | 2.9839 | 2.9839 | 33.1818 | 4.4 K | 1.3 K | 1.4 K | 522 | 503 | 499 | 216 | 216 | 216 | 216 | 216 | 248 | 236 |
| HOTH | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MBRX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ALLR | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 93.5685 | 5.8736 | 130 | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 4.5 K | 4.8 K |
| CTXR | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 14.4 K | 38 K | 34.2 K | 20.9 K |
My Equities
My Current Equities and Potential Positions
| Processa Pharmaceuticals | PCSA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 7380 Coca Cola |
| Exchange | NASDAQ Exchange |
USD 2.88
More Resources for Processa Stock Analysis
Reviewing Processa Pharmaceuticals commonly begins with financial statements and performance trends. Ratios and trend metrics help frame Processa Pharmaceuticals' operating context. Outlined below are key reports that provide context for Processa Pharmaceuticals Stock:Pair Processa Pharmaceuticals Performance with Processa Pharmaceuticals Correlation for supplemental context on Processa Pharmaceuticals. This supports a more complete research view. To understand the process of investing in Processa Stock, visit our How to Invest in Processa Pharmaceuticals guide.Analysis related to Processa Pharmaceuticals should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Technical analysis for Processa Pharmaceuticals evaluates price and volume patterns over time. Typical tools include moving averages, relative strength index, regressions, and price correlations.